DLX2 Antibody

Code CSB-PA006953DSR2HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human prostate cancer using CSB-PA006953DSR2HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human kidney tissue using CSB-PA006953DSR2HU at dilution of 1:100

Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) DLX2 Polyclonal antibody
Uniprot No.
Target Names
DLX2
Alternative Names
DII A antibody; Distal less homeo box 2 antibody; Distal less homeobox 2 antibody; DLX 2 antibody; Dlx2 antibody; DLX2_HUMAN antibody; Dlx5 antibody; Homeobox protein DLX 2 antibody; Homeobox protein DLX-2 antibody; Homeobox protein DLX2 antibody; Homeobox protein TES 1 antibody; Homeobox protein TES1 antibody; Tes 1 antibody; Tes1 antibody; zgc antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Homeobox protein DLX-2 protein (1-140AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Form
Liquid
Tested Applications
ELISA, IHC
Recommended Dilution
Application Recommended Dilution
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Acts as a transcriptional activator. Plays a role in terminal differentiation of interneurons, such as amacrine and bipolar cells in the developing retina. Likely to play a regulatory role in the development of the ventral forebrain. May play a role in craniofacial patterning and morphogenesis.
Gene References into Functions
  1. Mutant Runx2 regulates amelogenesis and osteogenesis through a miR-185-5p-Dlx2 axis. PMID: 29242628
  2. Authors characterized a BMP target gene, Distal-less homeobox 2 (DLX2), and found that DLX2 promoted apoptosis and neural differentiation of glioma-initiating cells. PMID: 28459464
  3. DLX2 is a novel marker of poor prognosis and sorafenib resistance in patients with hepatocellular carcinoma. PMID: 27302463
  4. High Ki67 expression is only present in 6.8% of CaP patients and is predictive of reduced survival and increased risk of metastasis, independent of PSA, Gleason score and D'Amico risk category. DLX2 is a novel marker of increased metastasis risk found in 73% patients and 8.2% showed co-expression with a high Ki67 score PMID: 27336609
  5. High DLX-2 expression is associated with epithelial-mesenchymal transition in cancer. PMID: 26771232
  6. DLX2 plays a crucial role in radioresistance, radiation-induced epithelial to mesenchymal transition and cancer stem cell marker expression, and the expression of DLX2 is regulated by Smad2/3 signaling in A549 and MDA-MB-231 cell lines. PMID: 26799321
  7. DLX2 expression reduces the protein components of the TTI1/TTI2/TEL2 complex, a key complex required for the proper folding and stabilization of ATM and other members of the PIKK family kinase, leading to reduced ATM-p53 signaling and senescence bypass PMID: 26833729
  8. Results showed that Dlx-2 is involved in TGF-beta- and Wnt-induced epithelial-mesenchymal transition, glycolytic switch, and mitochondrial repression by Snail activation. PMID: 25651912
  9. The activation of DLX2 signaling might improve tissue regeneration mediated by MSCs of dental origin. Results provide insight into the mechanism underlying the directed differentiation of MSCs of dental origin. PMID: 24756434
  10. Increased expression of DLX2 may correlate with the advanced stage of gastric adenocarcinoma, and it may contribute to tumor development. PMID: 23674878
  11. overexpression of DLX2 indicated poor survival in the 83 glioblastoma multiforme patients PMID: 23331016
  12. Dlx2 (and Dlx1) are required to generate cortical interneurons in the medial ganglionic eminence. PMID: 23312518
  13. Dlx-2 may be involved in tumor progression via the regulation of metabolic stress-induced necrosis PMID: 21917150
  14. MDA-MB-231 breast neoplasms expressed DLX2. PMID: 21108812
  15. In corroboration with paired-like homeodomain protein 2 (PITX2) protein kinase C functional studies, a newly identified carboxyl-terminal PITX2 mutation associated with Axenfeld-Rieger syndrome demonstrates reduced phosphorylation. PMID: 15751970
  16. In mice, biological and biochemical observations suggest that functional antagonism through heterodimer formation is a mechanism for regulating the transcriptional actions of Msx and Dlx homeoproteins. PMID: 9111364
  17. results in mutated mice suggest that Dlx2 controls development of branchial arches and the forebrian, suggesting a role in craniofacil evolution PMID: 7590232
  18. provides the sequence of human DLX2 and compares it to the murine gene. PMID: 8812481
  19. In mice osteoblasts, both Dlx2 and Dlx5 are coordinately induced by BMP2 as early as 30 minutes into their growth and differentiation. PMID: 12957859

Show More

Hide All

Subcellular Location
Nucleus.
Protein Families
Distal-less homeobox family
Database Links

HGNC: 2915

OMIM: 126255

KEGG: hsa:1746

STRING: 9606.ENSP00000234198

UniGene: Hs.419

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*